Skip to main content
. 2022 Jun 28;153:113350. doi: 10.1016/j.biopha.2022.113350

Table 4.

Network based repurposing studies using gene regulatory networks, DTI, Drug–disease, and side-effect association.

Study name Method Datasets Evaluation criteria
Gene regulatory networks and Gene expression Data
1 DTI prediction for repositioning [113] Network propagation, scoring based on neighborhood, random walks GEO repository for Gene expression data AUC - ROC
2 A network flow approach for repurposing with case study on prostate cancer [115] Maximum Flow OMIM, KEGG, PGDB, DrugBank Precision, Mean, Position
3 NFFinder [119] Statistical method for analysis Cmap, DrugMatrix, and GEO
4 System biology approach developed by a novel knowledge-driven method [121] Bayesian network-based approach Gene-gene interaction
5 Functional Module Method with case study of Prostate Cancer [145] Functional linkage network TCGA, LINCS, GEO, OMIM AUC - ROC
6 computational DR using Kolmogorov– Smirnov enrichment testing for [123] Enrichment (Kolmogorov–Smirnov) GEO and CTD
Protein–protein interaction networks
7 Network Analysis for potential DTI identification [146] SVM, Logistic regression, L1-regularization, KNN STRING, DrugBank, Gene cards Z score and Standard deviation
8 Comprehension of Complex disease using PPIN [112] Gene expression omnibus (GEO) Harmonic mean and Precision
9 Drug repurposing shared network of PPIs and genes [147] Similarity STRING and DrugBank
10 PPINs and MMP cellular model [148] Cross talk by analysis of betweenness centrality KEGG, OMIM and iRef Index database
Drug–target interactions
11 DTI prediction using Probabilistic soft logic [135] Soft probabilistic logic DrugBank, KEGG, DCDB, and Matador AUC, Precision, AUPR
12 Network-based inference for prediction of DTI [136] DrugBank AUC and Precision
13 Bayesian matrix factorization-based DTI prediction[111] Prediction based on Bayesian algorithm DrugBank and DTIs AUC
14 DTI prediction from integration of chemical and genomic spaces [138] Bi-partite graph ML DrugBank and DTIs AUC
15 Bipartite model for DTI prediction [139] Supervised method of network inference DrugBank and DTIs AUC-ROC, AUPR
Drug–disease and side-effect association
16 Drug repositioning methods based on network inference [149] CTD AUC-ROC
17 PREDICT, a method to infer the new indications [44] Logistic regression DrugBank, SIDER, KEGG (Drug), DCDB, Expression Atlas, OMIM AUC, precision
18 Clustering of Heterogeneous networks to repurpose the drugs [150] Clustering NCBI Gene, KEGG Medicus
19 Use of Side effects in Network based approaches to drug repurposing [151] Statistical analysis SIDER, FDA approved drugs